The Pharmaceutical Market: Argentina

Date: January 31, 2013
Pages: 142
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P8EA8446F07EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Argentina
Argentina Pharmaceuticals & Healthcare Report

Argentina's pharmaceutical market will become increasingly unattractive to multinational pharmaceutical companies, as the double-digit market growth has been mainly driven by the high inflation rate. The strict currency and import restrictions, as well as poor regulatory regime, have further undermined foreign drugmakers' revenue-generating opportunities. A potential currency devaluation in the future will increase Argentina's export of medicines to a certain extent, if the country's structural distorting policies have not eroded its local pharmaceutical production capacity.

Headline Expenditure Projections

Pharmaceuticals: ARS31.30bn (US$7.58bn) in 2011 to ARS39.60bn (US$8.74bn) in 2012; +26.5% in local currency terms and 15.3% in US dollar terms. The forecast has increased since Q412 due to exchange rate fluctuations from previous years, and high inflation rate forecast for 2012.

Healthcare: ARS156.12bn (US$37.82bn) in 2011 to ARS198.71bn (US$30.23bn) in 2012; +27.3% in local currency terms and +16% in US dollar terms. The forecast has increased since Q412 due to over 25% inflation rate forecast for 2012.

Medical devices: ARS3.77bn (US$913mn) in 2011 to ARS4.39bn (US$971mn) in 2012; +16.5% in local currency terms and 6.2% in US dollar terms. The US dollar forecast has decreased since Q412 due to exchange rate fluctuations.

Risk/Reward Rating: Argentina remains at the eighth place in BMI's RRRs in Q113. However, the poor regulatory regime and high inflation rate are still challenging for the multinational drug companies. The deteriorating business environment and protectionist policies will also have a negative impact on the market. Argentina's pharmaceutical market is expected to grow at double-digit rates through to 2016 in local currency terms, largely due to inflation.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Argentina Pharmaceuticals And Healthcare Industry SWOT
    Argentina Political SWOT
    Argentina Economic SWOT
    Argentina Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Americas Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

ARGENTINA – MARKET SUMMARY

REGULATORY REGIME

    Table: Product Registration, Annex I & II Listed Countries
    Biological Market Regulation
    Generic Regulation
    OTC Regulation
    Intellectual Property Rights
    Intellectual Property Environment
    IP Disputes
    Counterfeit Pharmaceuticals
    Pricing & Reimbursement
    Table: Major Measures
    Table: Taxes Paid by the Pharmaceutical Industry by Type, 2005-2007 (ARSmn)
    Pricing Regime
    Table: Pharmaceutical Price Build-Up
    Table: Drug Price Freeze, 2005-2008
    Reimbursement Regime
    Other Regulatory Issues

INDUSTRY TRENDS AND DEVELOPMENTS

    Epidemiology
    Healthcare System
    Healthcare Insurance
    Medical Tourism
    Medicinal Plants
    Research & Development
    Pharmaceutical R&D Investment, 2001-07
    Clinical Trials
    Medical Devices

INDUSTRY FORECAST SCENARIO

    Overall Market Forecast
    Table: Argentina Pharmaceutical Sales, Historical Data and Forecasts
    Key Growth Factors – Industry
    Table: Argentina Healthcare Expenditure Trends, Historical Data and Forecasts
      Table: Argentina Government Healthcare Expenditure Trends, Historical Data and Forecasts
      Table: Argentina Private Healthcare Expenditure Trends, Historical Data and Forecasts
      Key Growth Factors – Macroeconomic
      Prescription Drug Market Forecast
      Table: Argentina Prescription Drug Market Indicators, Historical Data and Forecasts
      Patented Drug Market Forecast
      Table: Argentina Patented Drug Market Indicators, Historical Data and Forecasts
      Generic Drug Market Forecast
      Table: Argentina Generics Drug Market Indicators, Historical Data and Forecasts
      OTC Medicine Market Forecast
      Table: Argentina Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts
      Pharmaceutical Trade Forecast
      Table: Argentina Pharmaceutical Trade Data And Forecasts (US$mn)
      Table: Argentina Pharmaceutical Trade Data And Forecasts (ARSmn)
      Medical Device Market Forecast
      Table: Argentina Medical Device Market Indicators, Historical Data and Forecasts
      Other Healthcare Forecasts
      Key Risks To BMI's Forecast Scenario

COMPETITIVE LANDSCAPE

      Pharmaceutical Industry
      Domestic Pharmaceutical Sector
      Table: Members of CAPDROFAR, 2012
      Table: Members of CAPGEN, 2012
      Table: Members of CILFA, 2012
      Table: Members of COOPERALA, 2012
      Foreign Pharmaceutical Sector
      Table: Members of CAEMe, 2012
      Table: Members of CAEMe, 2012
      Table: Members of CAPEMVeL, 2012
      Recent Company Developments
      Vaccines Sector
      Pharmaceutical Wholesale Sector
      Table: Members of ADEM, 2012
      Retail Pharmacy Sector

COMPANY PROFILES

  Local Companies
      Roemmers
      Laboratorios Bagó
  Multinational Companies
      Pfizer
      Roche
      Novartis
      GlaxoSmithKline
      Sanofi
      Merck & Co
      Boehringer Ingelheim

DEMOGRAPHIC OUTLOOK

    Table: Population By Age Group, 1990-2020 ('000)
    Table: Population By Age Group, 1990-2020 (% of total)
    Table: Key Population Ratios, 1990-2020
    Table: Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceutical Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Risk/Reward Indicators
    Weighting
    Table: Weighting Of Components
    Sources
Skip to top


The Pharmaceutical Market: Bulgaria US$ 1,295.00 Jan, 2013 · 92 pages
The Pharmaceutical Market: Chile US$ 1,295.00 Jan, 2013 · 141 pages
The Pharmaceutical Market: China US$ 1,295.00 Jan, 2013 · 118 pages
The Pharmaceutical Market: Colombia US$ 1,295.00 Jan, 2013 · 114 pages

Ask Your Question

The Pharmaceutical Market: Argentina
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: